{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:16:36Z","timestamp":1762254996180,"version":"build-2065373602"},"reference-count":36,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"publisher","award":["2017\/25\/B\/NZ5\/01131"],"award-info":[{"award-number":["2017\/25\/B\/NZ5\/01131"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterized by disruptions in the dystrophin gene. This study aims to investigate potential a therapeutic approach using genetically modified human iPS-derived mesoangioblast-like cells (HIDEMs) in mdx mouse model. This study utilizes patient-specific myoblasts reprogrammed to human induced pluripotent stem cells (iPSCs) and then differentiated into HIDEMs. Lentiviral vectors carrying microdystrophin sequences have been employed to deliver the genetic construct to express a shortened, functional dystrophin protein in HIDEMs. The study indicated significant changes within redox potential between healthy and pathological HIDEM cells derived from DMD patients studied by catalase and superoxide dismutase activities. Microdystrophin expressing HIDEMs also improved expression of genes involved in STARS (striated muscle activator of Rho signaling) pathway albeit in selective DMD patients (with mild phenotype). Although in vivo observations did not bring progress in the mobility of mdx mice with HIDEMs, microdystrophin interventions this may argue against \u201ctreadmill test\u201d as suitable for assessment of mdx mice recovery. Low-level signaling of the Rho pathway and inflammation-related factors in DMD myogenic cells can also contribute to the lack of success in a functional study. Overall, this research contributes to the understanding of DMD pathogenesis and provides insights into potential novel therapeutic strategy, highlighting the importance of personalized gene therapy.<\/jats:p>","DOI":"10.3390\/ijms252211869","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T05:30:53Z","timestamp":1730784653000},"page":"11869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In Vitro Gene Therapy Using Human iPS-Derived Mesoangioblast-Like Cells (HIDEMs) Combined with Microdystrophin (\u03bcDys) Expression as the New Strategy for Duchenne Muscular Dystrophy (DMD) Experimental Treatment"],"prefix":"10.3390","volume":"25","author":[{"given":"Marta","family":"Budzi\u0144ska","sequence":"first","affiliation":[{"name":"Institute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3433-6990","authenticated-orcid":false,"given":"Agnieszka","family":"Malcher","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-4470","authenticated-orcid":false,"given":"Agnieszka","family":"Zimna","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3275-3245","authenticated-orcid":false,"given":"Maciej","family":"Kurpisz","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics Polish Academy of Sciences, 60-479 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-Based Path to Newborn Screening for Duchenne Muscular Dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00858726","article-title":"The Clinical, Genetic and Dystrophin Characteristics of Becker Muscular Dystrophy\u2014II. Correlation of Phenotype with Genetic and Protein Abnormalities","volume":"240","author":"Bushby","year":"1993","journal-title":"J. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1096\/fj.12-224170","article-title":"Low Dystrophin Levels Increase Survival and Improve Muscle Pathology and Function in Dystrophin\/Utrophin Double-Knockout Mice","volume":"27","author":"Hulsker","year":"2013","journal-title":"FASEB J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(22)00012-5","article-title":"Repeated Intravenous Cardiosphere-Derived Cell Therapy in Late-Stage Duchenne Muscular Dystrophy (HOPE-2): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial","volume":"399","author":"McDonald","year":"2022","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"eaan0713","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic Administration of the Antisense Oligonucleotide NS-065\/NCNP-01 for Skipping of Exon 53 in Patients with Duchenne Muscular Dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nprot.2015.057","article-title":"Efficient Derivation and Inducible Differentiation of Expandable Skeletal Myogenic Cells from Human ES and Patient-Specific iPS Cells","volume":"10","author":"Maffioletti","year":"2015","journal-title":"Nat. Protoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/10715762.2013.835047","article-title":"Role of Exercise-Induced Reactive Oxygen Species in the Modulation of Heat Shock Protein Response","volume":"48","author":"Fittipaldi","year":"2014","journal-title":"Free Radic. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"R704","DOI":"10.1152\/ajpregu.00031.2006","article-title":"Dynamic Responses of the Glutathione System to Acute Oxidative Stress in Dystrophic Mouse (Mdx) Muscles","volume":"291","author":"Dudley","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.freeradbiomed.2007.04.003","article-title":"Low Intensity Training Decreases Markers of Oxidative Stress in Skeletal Muscle of Mdx Mice","volume":"43","author":"Kaczor","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11064-011-0683-z","article-title":"Oxidative Damage in Muscular Dystrophy Correlates with the Severity of the Pathology: Role of Glutathione Metabolism","volume":"37","author":"Renjini","year":"2012","journal-title":"Neurochem. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00454.2004","article-title":"Inflammatory Processes in Muscle Injury and Repair","volume":"288","author":"Tidball","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"982794","DOI":"10.1155\/2012\/982794","article-title":"Reactive Oxygen Species in Skeletal Muscle Signaling","volume":"2012","author":"Barbieri","year":"2012","journal-title":"J. Signal Transduct."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00424-014-1475-5","article-title":"The STARS Signaling Pathway: A key Regulator of Skeletal Muscle Function","volume":"466","author":"Lamon","year":"2014","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1113\/jphysiol.2009.168674","article-title":"Regulation of STARS and Its Downstream Targets Suggest a Novel Pathway Involved in Human Skeletal Muscle Hypertrophy and Atrophy","volume":"587","author":"Lamon","year":"2009","journal-title":"J. Physiol."},{"key":"ref_15","first-page":"147","article-title":"Serum Response Factor: Discovery, Biochemistry, Biological Roles and Implications for Tissue Injury Healing","volume":"53","author":"Chai","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0092-8674(05)80020-0","article-title":"The Rho Family GTPases RhoA, Racl, and CDC42Hsregulate Transcriptional Activation by SRF","volume":"81","author":"Hill","year":"1995","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81011-9","article-title":"Signal-Regulated Activation of Serum Response Factor is Mediated by Changes in Actin Dynamics","volume":"98","author":"Sotiropoulos","year":"1999","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0092-8674(03)00278-2","article-title":"Actin Dynamics Control SRF Activity by Regulation of its Coactivator MAL","volume":"113","author":"Miralles","year":"2003","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ajpath.2014.12.005","article-title":"Inhibition of Myocardin-Related Transcription Factor\/Serum Response Factor Signaling Decreases Lung Fibrosis and Promotes Mesenchymal Cell Apoptosis","volume":"185","author":"Sisson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_20","first-page":"1698","article-title":"Control of Myofibroblast Differentiation and Function by Cytoskeletal Signaling","volume":"81","author":"Sandbo","year":"2016","journal-title":"Biochemistry"},{"key":"ref_21","first-page":"e50532","article-title":"Transplantation of induced pluripotent stem cell-derived mesoangioblast-like myogenic progenitors in mouse models of muscle regeneration","volume":"83","author":"Gerli","year":"2014","journal-title":"J. Vis. Exp."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/hum.2019.255","article-title":"Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.Micro-Dystrophin in the Mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"32","author":"Potter","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of Systemic Delivery of rAAVrh74.MHCK7.Micro-Dystrophin in Children with Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/mt.2013.155","article-title":"Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: A Phase I\/IIa Clinical Study","volume":"22","author":"Trollet","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15252\/emmm.201505636","article-title":"Intra-arterial Transplantation of HLA -matched Donor Mesoangioblasts in Duchenne Muscular Dystrophy","volume":"7","author":"Cossu","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0960-8966(92)90023-Y","article-title":"Potential Oxyradical Damage and Energy Status in Individual Muscle Fibres from Degenerating Muscle Diseases","volume":"2","author":"Austin","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-2007-979768","article-title":"Oxyradical Damage and Mitochondrial Enzyme Activities in the Mdx Mouse","volume":"26","author":"Hauser","year":"1995","journal-title":"Neuropediatrics"},{"key":"ref_28","first-page":"e2857","article-title":"Rho GTPases, Oxidation, and Cell Redox Control","volume":"5","author":"Zhou","year":"2014","journal-title":"Small GTPases"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.07.013","article-title":"Tyr42 Phosphorylation of RhoA GTPase Promotes Tumorigenesis Through Nuclear Factor (NF)-\u03baB","volume":"112","author":"Kim","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/jcp.25572","article-title":"Wnt3A Induces GSK-3\u03b2 Phosphorylation and \u03b2-Catenin Accumulation Through RhoA\/ROCK","volume":"232","author":"Kim","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"C370","DOI":"10.1152\/ajpcell.00453.2002","article-title":"TNF-\u03b1 is a Mitogen in Skeletal Muscle","volume":"285","author":"Li","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1113\/EP089253","article-title":"Striated Muscle Activator of Rho Signalling (STARS) Overexpression in the Mdx Mouse Enhances Muscle Functional Capacity and Regulates the Actin Cytoskeleton and Oxidative Phosphorylation Pathways","volume":"106","author":"Sadler","year":"2021","journal-title":"Exp. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pediatrneurol.2019.05.005","article-title":"Impact of Age and Motor Function in a Phase 1\/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement Therapy","volume":"98","author":"Lowes","year":"2019","journal-title":"Pediatr. Neurol."},{"doi-asserted-by":"crossref","unstructured":"Fiedorowicz, K., Rozwadowska, N., Zimna, A., Malcher, A., Tutak, K., Szczerbal, I., Nowicka-Bauer, K., Nowaczyk, M., Kolanowski, T.J., and \u0141ab\u0119d\u017a, W. (2020). Tissue-specific Promoter-based Reporter System for Monitoring Cell Differentiation from iPSCs to Cardiomyocytes. Sci. Rep., 10.","key":"ref_35","DOI":"10.1038\/s41598-020-58050-2"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.omtm.2019.11.015","article-title":"Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult Mdx Mice","volume":"17","author":"Rodgers","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:26:34Z","timestamp":1760113594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/11869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":36,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252211869"],"URL":"https:\/\/doi.org\/10.3390\/ijms252211869","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}